CervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies


BOSTON, Aug. 22, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced its recent feature in Fortune magazine.

Continued here:
CervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies

Related Posts